Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease
This study has been completed.
Study NCT00058773
Information provided by Baylor College of Medicine
First Received: April 11, 2003
Last Updated: April 9, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
